About BioGaia AB 
BioGaia AB
Pharmaceuticals & Biotechnology
Biogaia AB is a Sweden-based company engaged in the development and sell of probiotic products, primarily based on the Lactobacillus reuteri bacteria. The Company’s activities are divided into three segments: Finished consumer products, which distributes tablets, drops, Oral Rehydration Solutions (ORSs), and oral health products, among others; Component products, which is responsible for the sale of LifeTop Straw and Life Top Cap, as well as of cultures as an ingredient in licensee products, such as infant formula and dairy products; and Other products, including animal health goods. It collaborates with Nestle, Gerber, Delta Medical, InfectoPharmm, Ferring Middle East, AllergyCare, and Ewopharma, among others. Furthermore, the Company operates worldwide through a number of subsidiaries, such as Biogaia Biologics Inc, CapAble AB, TwoPac AB and Infant Bacterial Therapeutics AB.
Company Coordinates 
Company Details
Kungsbroplan 3 , STOCKHOLM None : 112 27
Registrar Details
Shareholding Snapshot
No data for shareholding present.
Shareholding Compare (%holding) 
No data for shareholding present.
Management
Designation
Mr. Peter Rothschild
Chairman of the Board
Mr. David Dangoor
Independent Vice Chairman of the Board
Ms. Ewa Bjorling
Independent Director
Mr. Peter Elving
Independent Director
Ms. Inger Holmstrom
Independent Director
Mr. Anthon Jahreskog
Independent Director
Ms. Brit Stakston
Independent Director
Revenue and Profits:
Net Sales:
405 Million
(Quarterly Results - Jun 2025)
Net Profit:
88 Million
Pharmaceuticals & Biotechnology
SEK 10,165 Million (Small Cap)
37.00
NA
33.02%
-0.60
25.94%
8.35






